JNJ

188.98

-0.04%↓

ABT

123.58

-0.84%↓

TMO

568.01

+2.1%↑

ISRG

534.39

+0.84%↑

DHR

215.62

+0.34%↑

JNJ

188.98

-0.04%↓

ABT

123.58

-0.84%↓

TMO

568.01

+2.1%↑

ISRG

534.39

+0.84%↑

DHR

215.62

+0.34%↑

JNJ

188.98

-0.04%↓

ABT

123.58

-0.84%↓

TMO

568.01

+2.1%↑

ISRG

534.39

+0.84%↑

DHR

215.62

+0.34%↑

JNJ

188.98

-0.04%↓

ABT

123.58

-0.84%↓

TMO

568.01

+2.1%↑

ISRG

534.39

+0.84%↑

DHR

215.62

+0.34%↑

JNJ

188.98

-0.04%↓

ABT

123.58

-0.84%↓

TMO

568.01

+2.1%↑

ISRG

534.39

+0.84%↑

DHR

215.62

+0.34%↑

Search

Check Cap Ltd

Suletud

1.33 -2.21

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

1.33

Max

1.41

Põhinäitajad

By Trading Economics

Sissetulek

-9.4K

EBITDA

-1.3M

Turustatistika

By TradingEconomics

Turukapital

9.3M

Eelmine avamishind

3.54

Eelmine sulgemishind

1.33

Tehniline skoor

By Trading Central

Kindlus

Strong Bullish Evidence

Check Cap Ltd Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

31. okt 2025, 17:40 UTC

Omandamised, ülevõtmised, äriostud

Orange to Buy Lorca's 50% Stake in MasOrange for $4.9 Billion

31. okt 2025, 23:09 UTC

Tulu

Review & Preview: October Surprise -- Barrons.com

31. okt 2025, 22:44 UTC

Omandamised, ülevõtmised, äriostud

Pfizer Sues Seeking to Block Novo Nordisk's Effort to Undo Weight-Loss Drug Deal -- WSJ

31. okt 2025, 21:25 UTC

Market Talk
Omandamised, ülevõtmised, äriostud

Pfizer Says Novo Nordisk's Metsera Bid Won't Pass Antitrust Laws -- Market Talk

31. okt 2025, 21:20 UTC

Omandamised, ülevõtmised, äriostud

Pfizer Sues Seeking to Block Novo Nordisk's Effort to Undo Weight-Loss Drug Deal -- Update

31. okt 2025, 21:12 UTC

Omandamised, ülevõtmised, äriostud

Pfizer Sues Metsera, Novo Nordisk, Claiming Novo Nordisk Takeover Offer Isn't Superior -- WSJ

31. okt 2025, 21:12 UTC

Omandamised, ülevõtmised, äriostud

Pfizer Sues Seeking to Block Novo Nordisk's Effort to Undo Weight-Loss Drug Deal -- WSJ

31. okt 2025, 21:12 UTC

Omandamised, ülevõtmised, äriostud

Pfizer Seeks Order Blocking Metsera From Terminating Its Merger Deal With Pfizer -- WSJ

31. okt 2025, 20:51 UTC

Omandamised, ülevõtmised, äriostud

Another Rare-Earth Stock Jumps on Government Deal -- Barrons.com

31. okt 2025, 20:50 UTC

Market Talk

Financial Services Roundup: Market Talk

31. okt 2025, 20:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

31. okt 2025, 20:50 UTC

Market Talk
Tulu

Auto & Transport Roundup: Market Talk

31. okt 2025, 20:46 UTC

Omandamised, ülevõtmised, äriostud

Pfizer: Files Lawsuit Against Metsera and Its Directors and Novo Nordisk for Breach of Merger Agreement

31. okt 2025, 20:22 UTC

Tulu

Amazon Stock Hits New Record. What Was So Good in Its Earnings Report. -- Barrons.com

31. okt 2025, 20:02 UTC

Tulu

Meta Faces a Sudden Reckoning. How Big Tech Earnings Are Reshaping the AI Race. -- Barrons.com

31. okt 2025, 19:55 UTC

Market Talk

Crude Futures Fall for Third Straight Month -- Market Talk

31. okt 2025, 19:54 UTC

Omandamised, ülevõtmised, äriostud

Pfizer: FTC Granted Early Termination of Waiting Period >PFE

31. okt 2025, 19:54 UTC

Omandamised, ülevõtmised, äriostud

Pfizer: Receives Early Clearance From FTC for Metsera Acquisition

31. okt 2025, 19:26 UTC

Market Talk

U.S. Natural Gas Rises on Winter Outlook, Strong LNG -- Market Talk

31. okt 2025, 18:30 UTC

Tulu

These Stocks Are Moving the Most Today: Amazon, Nvidia, Apple, Netflix, Exxon, DexCom, Coinbase, Reddit, Newell Brands, and More -- Barrons.com

31. okt 2025, 18:23 UTC

Market Talk

Gold Edges Lower for the Day, Closes October Positive -- Market Talk

31. okt 2025, 18:09 UTC

Tulu

Bank of America Has a Game Plan to Catch Up to Its Peers. It's Time to Buy the Stock. -- Barrons.com

31. okt 2025, 18:08 UTC

Tulu

Bank of America Has a Game Plan to Catch Up to Its Peers. It's Time to Buy the Stock. -- Barrons.com

31. okt 2025, 17:36 UTC

Market Talk

Grain Futures Shrug Off Stronger Dollar -- Market Talk

31. okt 2025, 17:31 UTC

Market Talk

U.S. Oil Rig Count Falls, Natural Gas Rig Count Rises -- Market Talk

31. okt 2025, 17:16 UTC

Omandamised, ülevõtmised, äriostud

Orange: Acquisition Likely Completed in First Half Next Year

31. okt 2025, 17:15 UTC

Omandamised, ülevõtmised, äriostud

Orange: Agreement Set to Be Signed By Year-Out

31. okt 2025, 17:14 UTC

Omandamised, ülevõtmised, äriostud

Orange: Acquisition Will Strengthen Position in Spain

31. okt 2025, 17:13 UTC

Omandamised, ülevõtmised, äriostud

Orange Will Be Sole Owner of Spain's MasOrange Following Acquisition of Lorca's Stake

31. okt 2025, 17:12 UTC

Omandamised, ülevõtmised, äriostud

Orange Reaches Deal to Buy Lorca's 50% Stake in MasOrange for EUR4.25B

Võrdlus sarnastega

Hinnamuutus

Check Cap Ltd Prognoos

Hinnangu Konsensus

By TipRanks

0 ratings

0

Osta

0

Hoia

0

Müü

Tehniline skoor

By Trading Central

0.73 / 0.96Toetus ja vastupanu

Lühikene perspektiiv

Strong Bullish Evidence

Keskpikk perspektiiv

Weak Bullish Evidence

Pikk perspektiiv

Weak Bearish Evidence

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

$

Ettevõttest Check Cap Ltd

Check-Cap Ltd., a clinical stage medical diagnostics company, engages in the development of a capsule-based screening technology that utilizes ultra-low-dose X-rays to scan the inner lining of the colon for precancerous polyps, and other structural abnormalities in Israel. Its C-Scan system consists of C-Scan Cap, an X-ray scanning capsule for detection of suspected polyps; C-Scan Track, a disposable system attached to the patient's back through biocompatible adhesive skin patches; and C-Scan View software, a client/server-based application that enables procedure data download from the C-Scan Track, data analysis, and report generation. The company was incorporated in 2004 and is based in Isfiya, Israel.
help-icon Live chat